Skip to content

Association of Continuous Glucose Monitoring-derived Glycaemic Variables With Maternal Metabolome and Large for Gestational Age in Patients With Gestational Diabetes

Association of Continuous Glucose Monitoring-derived Glycaemic Variables With Maternal Metabolome and Large for Gestational Age in Patients With Gestational Diabetes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036260
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus

Interventions

LGA group vs non-LGA group:N/A

Sponsors

Shanghai Shenkang Hospital Development Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Obtain informed consent; 2. The 2020 ADA diagnostic criteria for GDM patients: 75 g oral glucose tolerance test (OGTT) during pregnancy, with blood glucose reaching or exceeding any of the following points can be diagnosed: (1) fasting blood glucose >= 5.1mmol/L; (2) Blood glucose >= 10.0mmol/L for 1 hour; (3) 2-hour blood glucose >= 8.5mmol/L; 3. Single pregnancy; 4. Aged 18-45 years; 5. 24-32 weeks gestation of pregnancy; 6. Prepregnancy BMI >= 18kg/m2.

Exclusion criteria

Exclusion criteria: 1. Diabetes combined with pregnancy (pregnancy based on the original diabetes); 2. Severe hepatic and renal dysfunction (ALT 2.5 times higher than normal upper limit, creatinine greater than 132ummol/L); 3. Drugs (including steroids, hydroxyprogesterone, anti-AIDS drugs, etc.) that may affect blood sugar are being used; 4. Co-infection; 5. Unable to fully understand the requirements of the project, poor compliance, and unwilling to use IPRO2.

Design outcomes

Secondary

MeasureTime frame
Preterm, macrosomia, SGA;Composite endpoint of neonatal complications;

Primary

MeasureTime frame
Incidence of LGA;

Countries

China

Contacts

Public ContactYufan Wang

Shanghai General Hospital

yyffwangdr@yahoo.com+86 13611889874

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026